Citadel Advisors’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-168,272
| Closed | -$65K | – | 5631 |
|
|
2020
Q1 | $65K | Buy |
168,272
+66,143
| +65% | +$25.6K | ﹤0.01% | 4491 |
|
|
2019
Q4 | $42K | Buy |
+102,129
| New | +$42K | ﹤0.01% | 4416 |
|
|
2019
Q3 | – | Sell |
-25,391
| Closed | -$55K | – | 5362 |
|
|
2019
Q2 | $55K | Buy |
25,391
+8,177
| +48% | +$17.7K | ﹤0.01% | 4343 |
|
|
2019
Q1 | $54K | Buy |
17,214
+2,015
| +13% | +$6.32K | ﹤0.01% | 4216 |
|
|
2018
Q4 | $38K | Buy |
15,199
+2,194
| +17% | +$5.49K | ﹤0.01% | 4145 |
|
|
2018
Q3 | $52K | Buy |
+13,005
| New | +$52K | ﹤0.01% | 4004 |
|
|
2017
Q4 | – | Sell |
-16,339
| Closed | -$35K | – | 4458 |
|
|
2017
Q3 | $35K | Sell |
16,339
-2,768
| -14% | -$5.93K | ﹤0.01% | 3448 |
|
|
2017
Q2 | $86K | Buy |
19,107
+4,971
| +35% | +$22.4K | ﹤0.01% | 3321 |
|
|
2017
Q1 | $42K | Sell |
14,136
-14,172
| -50% | -$42.1K | ﹤0.01% | 3430 |
|
|
2016
Q4 | $78K | Buy |
28,308
+3,969
| +16% | +$10.9K | ﹤0.01% | 3265 |
|
|
2016
Q3 | $76K | Buy |
24,339
+8,262
| +51% | +$25.8K | ﹤0.01% | 3236 |
|
|
2016
Q2 | $82K | Buy |
+16,077
| New | +$82K | ﹤0.01% | 2991 |
|
|
2016
Q1 | – | Sell |
-11,598
| Closed | -$94K | – | 4217 |
|
|
2015
Q4 | $94K | Buy |
11,598
+3,956
| +52% | +$32.1K | ﹤0.01% | 3273 |
|
|
2015
Q3 | $64K | Sell |
7,642
-10,390
| -58% | -$87K | ﹤0.01% | 3493 |
|
|
2015
Q2 | $170K | Buy |
18,032
+12,896
| +251% | +$122K | ﹤0.01% | 3099 |
|
|
2015
Q1 | $48K | Buy |
5,136
+1,095
| +27% | +$10.2K | ﹤0.01% | 3395 |
|
|
2014
Q4 | $37K | Buy |
+4,041
| New | +$37K | ﹤0.01% | 3476 |
|
|
2014
Q3 | – | Sell |
-11,086
| Closed | -$87K | – | 3850 |
|
|
2014
Q2 | $87K | Sell |
11,086
-11,443
| -51% | -$89.8K | ﹤0.01% | 3027 |
|
|
2014
Q1 | $178K | Buy |
22,529
+8,088
| +56% | +$63.9K | ﹤0.01% | 2886 |
|
|
2013
Q4 | $90K | Buy |
14,441
+3,659
| +34% | +$22.8K | ﹤0.01% | 2661 |
|
|
2013
Q3 | $38K | Buy |
10,782
+4,918
| +84% | +$17.3K | ﹤0.01% | 2648 |
|
|
2013
Q2 | $11K | Buy |
+5,864
| New | +$11K | ﹤0.01% | 2690 |
|